Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
HMO Practice|May 8, 1992
Evaluation of wellness in an eating disorders programJ Sampson, M Canterbury, L ReinhardtThe Journal of Clinical Endocrinology and Metabolism|September 1, 1977
Parathyroid hormone and the hypercalcemia of immobilizationS Lerman, J M Canterbury, E ReissThe Journal of Clinical Investigation|February 1, 1973
Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragmentsJ M Canterbury, G S Levey, E ReissThe Journal of Clinical Investigation|August 1, 1972
Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levelsW Jubiz, J M Canterbury, E Reiss, et al.The Journal of Clinical Investigation|March 1, 1980
Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogsJ M Canterbury, G Gavellas, J J Bourgoignie, et al.The Journal of Clinical Investigation|November 1, 1970
The role of phosphate in the secretion of parathyroid hormone in manE Reiss, J M Canterbury, M A Bercovitz, et al.The Journal of Clinical Investigation|January 1, 1973
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuriaF L Coe, J M Canterbury, J J Firpo, et al.The American Journal of Medicine|June 1, 1980
Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidismN A Breslau, D D Notman, J M Canterbury, et al.The Journal of Clinical Investigation|May 1, 1978
Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dogJ M Canterbury, S Lerman, A J Claflin, et al.The Journal of Clinical Investigation|June 1, 1981
Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogsA I Jacob, J M Canterbury, G Gavellas, et al.Pageof 3